| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMAPSYCHIATRY.2013.1270 |
| P8608 | Fatcat ID | release_mtnbeicp4rfh7j4igq4ljkqjem |
| P698 | PubMed publication ID | 23739772 |
| P5875 | ResearchGate publication ID | 237059619 |
| P50 | author | Patrick McGorry | Q7147153 |
| Barnaby Nelson | Q62583760 | ||
| Magenta B Simmons | Q87593935 | ||
| Ashleigh Lin | Q87802285 | ||
| Shona M Francey | Q90337088 | ||
| G Paul Amminger | Q95991037 | ||
| Annie Bruxner | Q114422721 | ||
| Daniela Spiliotacopoulos | Q114422723 | ||
| Christina Broussard | Q114422724 | ||
| Warrick J Brewer | Q114422725 | ||
| Alison R. Yung | Q37835108 | ||
| Stephen J Wood | Q42733695 | ||
| Andrew Thompson | Q58325838 | ||
| Hok Pan Yuen | Q60659048 | ||
| P2093 | author name string | Debra L Foley | |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 793-802 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. | |
| P478 | volume | 70 |
| Q47233520 | A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China |
| Q33670654 | A critique of the "ultra-high risk" and "transition" paradigm |
| Q47614456 | A new method for analysing transition to psychosis: Joint modelling of time-to-event outcome with time-dependent predictors. |
| Q26748778 | A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis |
| Q38819011 | A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis |
| Q33817901 | Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state |
| Q47591831 | Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate. |
| Q52565127 | Altered functional connectivity strength and its correlations with cognitive function in subjects with ultra-high risk for psychosis at rest. |
| Q50581438 | An Elective in College Mental Health for Training Adult Psychiatry Residents in Young Adult Psychiatry. |
| Q57519639 | Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study |
| Q38258292 | Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis. |
| Q93369149 | Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis |
| Q88963682 | At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging |
| Q38902686 | Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis |
| Q46228189 | Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort |
| Q55278928 | Beyond the "at risk mental state" concept: transitioning to transdiagnostic psychiatry. |
| Q38792309 | Bipolar At-risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders |
| Q48089122 | Borderline personality pathology in young people at ultra high risk of developing a psychotic disorder |
| Q31099010 | Brain change trajectories that differentiate the major psychoses. |
| Q47885387 | Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis. |
| Q26770197 | Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis |
| Q40746465 | Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis. |
| Q36221808 | Classifying individuals at high-risk for psychosis based on functional brain activity during working memory processing |
| Q91273932 | Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis |
| Q34701054 | Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. |
| Q47627875 | Clinical psychopathology in youth at familial high risk for psychosis |
| Q93051360 | Compensatory Cognitive Training for Latino Youth at Clinical High Risk for Psychosis: Study Protocol for a Randomized Controlled Trial |
| Q50617047 | Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial. |
| Q47837277 | Course of clinical high-risk states for psychosis beyond conversion |
| Q52689700 | Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective. |
| Q34123531 | Current status specifiers for patients at clinical high risk for psychosis |
| Q38965039 | D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. |
| Q90911779 | DSM outcomes of psychotic experiences and associated risk factors: 6-year follow-up study in a community-based sample |
| Q43855499 | Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service. |
| Q36617938 | Demographic correlates of attenuated positive psychotic symptoms |
| Q35096522 | Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers |
| Q38584936 | Detection and treatment of at-risk mental state for developing a first psychosis: making up the balance |
| Q26822553 | Developing psychosis and its risk states through the lens of schizotypy |
| Q39919011 | Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders. |
| Q26795451 | Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis |
| Q48279750 | Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder. |
| Q40051964 | Do fewer males present to clinical high-risk services for psychosis relative to first-episode services? |
| Q41651638 | Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome |
| Q36377868 | EEG-Informed fMRI Reveals a Disturbed Gamma-Band-Specific Network in Subjects at High Risk for Psychosis |
| Q38950158 | Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health. |
| Q48527862 | Early referral and comorbidity as possible causes of the declining transition rate in subjects at clinical high risk for psychosis |
| Q41197083 | Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome. |
| Q64267299 | Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis |
| Q30371792 | Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective. |
| Q36955474 | Emotional Experiences Predict the Conversion of Individuals with Attenuated Psychosis Syndrome to Psychosis: A 6-Month Follow up Study |
| Q33635566 | Erythrocyte glutathione levels as long-term predictor of transition to psychosis |
| Q38870720 | Ethical and Epidemiological Dimensions of Labeling Psychosis Risk |
| Q64934942 | Evaluation of the Combined Treatment Approach "Robin" (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis. |
| Q90392421 | Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes |
| Q39905473 | Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. |
| Q64054968 | Functional deficits in attenuated psychosis syndrome and related conditions: Current and future treatment options |
| Q96817727 | Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia |
| Q30845062 | Glutamate-mediated excitotoxicity in schizophrenia: a review |
| Q90748306 | Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study |
| Q41084707 | Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis |
| Q31122156 | Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation |
| Q41658737 | Improving outcomes of first-episode psychosis: an overview |
| Q64912155 | Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis. |
| Q93069431 | Inefficient neural system stabilization: a theory of spontaneous resolutions and recurrent relapses in psychosis |
| Q42052561 | Insights into psychosis risk from leukocyte microRNA expression |
| Q50596157 | Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis. |
| Q47620192 | Interpersonal sensitivity and persistent attenuated psychotic symptoms in adolescence |
| Q58726692 | Isolated hallucination is less predictive than thought disorder in psychosis: Insight from a longitudinal study in a clinical population at high risk for psychosis |
| Q47653030 | Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction |
| Q37031821 | Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study |
| Q57469559 | Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-up |
| Q36378238 | Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis. |
| Q91710809 | Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review |
| Q57494356 | Motor clusters reveal differences in risk for psychosis, cognitive functioning, and thalamocortical connectivity: evidence for vulnerability subtypes |
| Q50573955 | NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. |
| Q55330019 | NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course. |
| Q48001314 | Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis |
| Q47990667 | Neuroanatomical Predictors of Functional Outcome in Individuals at Ultra-High Risk for Psychosis. |
| Q27011767 | North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms |
| Q47651190 | Perceptual abnormalities in an ultra-high risk for psychosis population relationship to trauma and co-morbid disorder |
| Q31139079 | Performance of joint modelling of time-to-event data with time-dependent predictors: an assessment based on transition to psychosis data |
| Q60545795 | Persistent negative symptoms in individuals at Ultra High Risk for psychosis. |
| Q41630931 | Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. |
| Q89692219 | Physical Illnesses Before Diagnosed as Schizophrenia: A Nationwide Case-Control Study |
| Q47411862 | Physical health promotion for young people at ultra-high risk for psychosis: An application of the COM-B model and behaviour-change wheel. |
| Q39824871 | Polish individuals with an at-risk mental state: demographic and clinical characteristics |
| Q38831631 | Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis |
| Q90049288 | Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study |
| Q39123249 | Prediction and prevention of psychosis: current progress and future tasks |
| Q37682795 | Prediction and prevention of the first psychotic episode: new directions and opportunities. |
| Q47553771 | Prediction of psychosis across protocols and risk cohorts using automated language analysis |
| Q104467073 | Prediction of psychosis: model development and internal validation of a personalized risk calculator |
| Q37307208 | Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers |
| Q39018992 | Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting |
| Q35034786 | Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids |
| Q35621468 | Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders |
| Q36910682 | Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians |
| Q39177987 | Progression from unipolar depression to schizophrenia |
| Q47817713 | Psychological, social and role functioning as predictors of psychosis in an adolescent psychiatric sample |
| Q37194050 | Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program |
| Q35214828 | Psychosis risk syndrome is not prodromal psychosis |
| Q92533533 | Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2) |
| Q34203122 | Reduction in incidence of hospitalizations for psychotic episodes through early identification and intervention |
| Q34270086 | Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis |
| Q34508665 | Self-Disorders and Clinical High Risk for Psychosis: An Empirical Study in Help-Seeking Youth Attending Community Mental Health Facilities |
| Q102058975 | Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning |
| Q36377966 | Severity of thought disorder predicts psychosis in persons at clinical high-risk |
| Q37699336 | Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population. |
| Q35950862 | Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis |
| Q39441772 | Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients. |
| Q38812229 | Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model. |
| Q34987780 | Substance use in people at clinical high-risk for psychosis. |
| Q51731922 | Surface morphology of the orbitofrontal cortex in individuals at risk of psychosis: a multicenter study. |
| Q30604468 | Symptom trajectories and psychosis onset in a clinical high-risk cohort: the relevance of subthreshold thought disorder |
| Q55383317 | The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths. |
| Q39231447 | The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms |
| Q33581212 | The Role of Trauma and Stressful Life Events among Individuals at Clinical High Risk for Psychosis: A Review |
| Q90336796 | The benefit of foresight? An ethical evaluation of predictive testing for psychosis in clinical practice |
| Q48065701 | The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state |
| Q55515865 | The impact of psychotic experiences in the early stages of mental health problems in young people. |
| Q95333318 | The need for Early Intervention for Psychosis to persist throughout the covid-19 pandemic and beyond |
| Q34322953 | The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study |
| Q47916430 | Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls |
| Q35006376 | Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence |
| Q38260578 | Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome |
| Q101120954 | Transdiagnostic individualized clinically-based risk calculator for the automatic detection of individuals at-risk and the prediction of psychosis: external replication in 2,430,333 US patients |
| Q34446370 | Trauma history characteristics associated with mental states at clinical high risk for psychosis |
| Q61809179 | Two-Year Clinical and Functional Outcomes of an Asian Cohort at Ultra-High Risk of Psychosis |
| Q50533618 | Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. |
| Q37274686 | Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome |
| Q38667771 | Understanding auditory verbal hallucinations: a systematic review of current evidence |
| Q33814290 | Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis. |
| Q90570746 | Validation of the Korean Version of the 15-Item Community Assessment of Psychic Experiences in a College Population |
| Q55381753 | Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population. |
| Q45358413 | Varieties of self-disturbance: a prism through which to view mental disorder. |
| Q38697215 | Ventricular volumes across stages of schizophrenia and other psychoses |
| Q39340073 | What impact does trauma have on the at-risk mental state? A systematic literature review |
| Q36102040 | White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids. |
| Q47831475 | Youth mental health services in Italy: An achievable dream? |
Search more.